Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Rheumatology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

story of the week
Published in Rheumatology

Journal Scan / Research · September 12, 2022

Methotrexate Improves Pain and Inflammation in Patients With Arthralgia But Does Not Prevent Progression to Clinical Arthritis

The Lancet


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
Lancet 2022 Jul 23;400(10348)283-294, DI Krijbolder, M Verstappen, BT van Dijk, YJ Dakkak, LE Burgers, AC Boer, YJ Park, ME de Witt-Luth, K Visser, MR Kok, ETH Molenaar, PHP de Jong, S Böhringer, TWJ Huizinga, CF Allaart, E Niemantsverdriet, AHM van der Helm-van Mil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading